TF and breast carcinoma: Patients with pancreatic, colorectal, brain, prostate, and breast cancer have higher levels of plasma TF/PS-expressing MPs and higher MP-associated pro-thrombotic activity than healthy subjects, especially during advanced stages of disease and after chemotherapy or radiotherapy (104–110).